1Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer's diseaseYanxin Shen, Guimei Zhang, Chunxiao Wei, Panpan Zhao, Yongchun Wang, Mingxi Li, Li Sun613-6312Cell polarization in ischemic stroke:molecular mechanisms and advancesYuanwei Li, Xiaoxiao Xu, Xuan Wu, Jiarui Li, Shiling Chen, Danyang Chen, Gaigai Li, Zhouping Tang632-6453Toward understanding the role of genomic repeat elements in neurodegenerative diseasesZhengyu An, Aidi Jiang, Jingqi Chen646-6594From single to combinatorial therapies in spinal cord injuries for structural and functional restorationErnesto Doncel-Pérez, Gabriel Guízar-Sahagún, Israel Grijalva-Otero660-6705Crosstalk between degradation and bioenergetics:how autophagy and endolysosomal processes regulate energy productionAngelid Pabon, Jagannatham Naidu Bhupana, Ching-On Wong671-6816Corrigendum6817Context-dependent role of sirtuin 2 in inflammationNoemí Sola-Sevilla, Maider Garmendia-Berges, MCarmen Mera-Delgado, Elena Puerta682-6948Liver as a new target organ in Alzheimer's disease:insight from cholesterol metabolism and its role in amyloid-beta clearanceBeibei Wu, Yuqing Liu, Hongli Li, Lemei Zhu, Lingfeng Zeng, Zhen Zhang, Weijun Peng695-7149Targeting TrkB-PSD-95 coupling to mitigate neurological disordersXin Yang, Yu-Wen Alvin Huang, John Marshall715-72410Spastin and alsin protein interactome analyses begin to reveal key canonical pathways and suggest novel druggable targetsBenjamin R.Helmold, Angela Ahrens, Zachary Fitzgerald, P.Hande Ozdinler725-73911Lipid droplets in the nervous system:involvement in cell metabolic homeostasisYuchen Zhang, Yiqing Chen, Cheng Zhuang, Jingxuan Qi, Robert Chunhua Zhao, Jiao Wang740-75012Role of copper chelating agents:between old applications and new perspectives in neuroscienceRosalba Leuci, Leonardo Brunetti, Vincenzo Tufarelli, Marco Cerini, Marco Paparella, Nikola Puvača, Luca Piemontese751-76213Meningeal lymphatic vessel crosstalk with central nervous system immune cells in aging and neurodegenerative diseasesMinghuang Gao, Xinyue Wang, Shijie Su, Weicheng Feng, Yaona Lai, Kongli Huang, Dandan Cao, Qi Wang763-77814Infiltration by monocytes of the central nervous system and its role in multiple sclerosis:reflections on therapeutic strategiesGuangyong Zhang, Qing Yao, Chubing Long, Pengcheng Yi, Jiali Song, Luojia Wu, Wei Wan, Xiuqin Rao, Yue Lin, Gen Wei, Jun Ying, Fuzhou Hua779-79315Mitochondrial therapeutics and mitochondrial transfer for neurodegenerative diseases and agingNeville Ng, Michelle Newbery, Nicole Miles, Lezanne Ooi794-79616Injury/ischemia-induced stem cells:up-to-date knowledge and future perspectives for neural regenerationTakayuki Nakagomi797-79817Insights from a proteomic atlas of human Alzheimer's disease brain tissueTomas Kavanagh, Eleanor Drummond799-80018Decoding complexity:the need to enhance precision and streamline spatial understanding in neuroscienceSameehan Mahajani, Armita Salahi, Brenda Gonzalez, Charlotte Nelson, Frank Hsiung801-80219Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathiesGlenn A.Harris, Lauren R.Hirschfeld803-80420Mitochondria-cGAS-STING axis is a potential therapeutic target for senescence-dependent inflammaging-associated neurodegenerationJosé M.Izquierdo805-807 